MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$7,260K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income (loss)
Proceeds from stock option exerc...
Inventories
Others
Negative Cash Flow Breakdown
Accounts receivable
Repayment of long-term debt
Other non-current assets and lia...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
11,578
1,554
1,483
-1,927
Stock-based compensation
1,468
1,518
1,124
1,092
Depreciation and amortization
1,386
1,131
1,017
1,009
Inventory step-up
650
350
1,421
1,324
Excess and obsolete inventory reserve
354
227
594
-
Debt discount amortization and non-cash interest expenses
160
118
175
179
Non-cash lease expense
36
9
9
5
Other operating activity
-
-7
-
-
Accounts receivable
11,478
1,651
-1,325
-1,371
Inventories
-3,319
-1,406
581
-5,614
Prepaid expenses and other assets
1,015
-1,754
2,521
122
Accounts payable
921
2,508
-3,284
2,122
Accrued medicaid rebates
-172
1,824
-8,714
1,806
Accrued liabilities
2,236
-1,532
426
1,786
Other non-current assets and liabilities
2,181
1,818
4,025
2,233
Acquisition of business
-
-
0
-
Net cash from operating activities
7,255
7,405
-11,551
12,026
Purchases of product license rights
0
15,000
0
0
Purchases of property and equipment
-5
75
49
284
Net cash used in investing activities
5
-15,075
-49
-284
Net proceeds from the issuance of long-term debt
-
-
0
-
Repayment of long-term debt
-
-
0
0
Common stock issued in private placement offering
-
-
0
-
Proceeds from stock option exercises
4,043
-
598
-
Payment of tax withholding related to net share settlement of stock option exercises
-
-
0
-
Proceeds from shares issued under the espp
-1,119
1,389
-177
0
Repayment of long-term debt
-3,000
-
-
-
Net cash from financing activities
-76
1,389
421
0
Change in cash and cash equivalents
7,184
-6,281
-11,179
11,742
Cash and cash equivalents at beginning of period
19,661
25,942
37,121
14,936
Cash and cash equivalents at end of period
26,845
19,661
25,942
37,121
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$11,578K
(378.52%↑ Y/Y)
Purchases of property and
equipment
-$5K
Inventories
-$3,319K
(-130.42%↓ Y/Y)
Accrued liabilities
$2,236K
(286.18%↑ Y/Y)
Stock-based compensation
$1,468K
(-55.46%↓ Y/Y)
Depreciation and
amortization
$1,386K
(-31.32%↓ Y/Y)
Accounts payable
$921K
(-88.44%↓ Y/Y)
Inventory step-up
$650K
(-72.33%↓ Y/Y)
Excess and obsolete
inventory reserve
$354K
Debt discount
amortization and non-cash...
$160K
(-53.22%↓ Y/Y)
Non-cash lease expense
$36K
(20.00%↑ Y/Y)
Net cash from
operating activities
$7,255K
(-27.80%↓ Y/Y)
Net cash used in
investing activities
$5K
Canceled cashflow
$14,846K
Change in cash and cash
equivalents
$7,184K
(-31.21%↓ Y/Y)
Canceled cashflow
$76K
Accounts receivable
$11,478K
(26.24%↑ Y/Y)
Other non-current
assets and liabilities
$2,181K
(123.27%↑ Y/Y)
Prepaid expenses and
other assets
$1,015K
(251.04%↑ Y/Y)
Accrued medicaid
rebates
-$172K
(-101.84%↓ Y/Y)
Proceeds from stock
option exercises
$4,043K
Net cash from
financing activities
-$76K
(-119.29%↓ Y/Y)
Canceled cashflow
$4,043K
Repayment of long-term
debt
-$3,000K
Proceeds from shares
issued under the espp
-$1,119K
(-384.01%↓ Y/Y)
Buy us a coffee
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)